The federal committee that advises the Department of Health and Human Services on vaccine policy is now operating under a charter that directs it to examine what people might do instead of getting vaccinated. The document carries a filing date of July 7, 2026, and was posted on the HHS website without an announcement, a sequence first flagged in reporting by STAT.
The current charter for the National Vaccine Advisory Committee states that the program and the committee should consider and coordinate with broader communicable disease authorities, including non-immunization strategies for individuals who are unable to be vaccinated or who choose not to be vaccinated due to medical contraindications or strongly held personal, conscientious, or religious beliefs.
It then specifies those strategies. They should include healthy lifestyle and disease-prevention initiatives, off-label repurposed uses of existing FDA-approved drugs, and the use of dietary supplements known to support healthy immune function.
The Language That Was Not There Before
Reporting on the change describes NVAC as a body that previously concentrated on the safest and most effective use of vaccines, with membership drawn largely from vaccine researchers, physicians and public health officials. The passage about non-immunization strategies, repurposed drugs and supplements is new to the committee's stated objectives.
The change extends into the subcommittee provisions, which list topics the committee may take up. Alongside conventional subjects such as identifying people at higher risk of adverse reactions based on medical history, age, sex, genetic susceptibility, and immune dysregulation, the charter now names opportunities to boost natural immunity through a healthy lifestyle and the development of personalized vaccinology approaches.
The charter does not define which dietary supplements it has in mind, identify which drugs qualify, or cite evidence that any of these approaches substitute for immunization against a specific pathogen. It sets an agenda rather than making a scientific claim.
What This Committee Can and Cannot Do
The distinction matters because the National Vaccine Advisory Committee is frequently confused with the Advisory Committee on Immunization Practices, and they do different jobs.
The ACIP advises the CDC director on how vaccines should be used, and its recommendations flow into insurance coverage requirements, the Vaccines for Children program, and state practice rules. NVAC advises the Director of the National Vaccine Program, a role held by the Assistant Secretary for Health, on the program's statutory responsibilities under Section 2105 of the Public Health Service Act.
Those functions are listed in the charter: studying and recommending ways to encourage an adequate supply of safe and effective vaccination products, recommending research priorities and measures to enhance vaccine safety and efficacy, advising on implementation of two other sections of the act, and identifying annually the most important areas of governmental and non-governmental cooperation.
Nothing NVAC produces binds anyone. It writes reports and recommendations. Its influence runs through agenda-setting, the framing of what counts as a live policy question, and the credibility its membership lends to conclusions. That is why a change to its stated objectives is worth reporting even though no rule changed.
Membership Rules Rewritten Around Who Is Kept Out
The charter also reworks the composition of the panel. The committee consists of 17 voting members: 15 public members, including the chair, plus two individuals designated to represent the vaccine manufacturing industry.
Two caps appear in the membership section. No more than one-third of the committee may come from the pharmaceutical industry or from academia with funding from pharmaceutical companies or from organizations that receive such funding. Separately, academic members should not exceed one-third of the membership. Members of the public should not be less than one-third.
Read together, those provisions narrow the pool of people who have spent careers studying vaccines, since much of that research is industry-funded. The charter also states that the Director shall consult the National Academy of Sciences regarding potential appointees, but that this consultation is advisory and non-binding.
Other operating details are unchanged in substance. The committee must meet at least three times a year, notice of meetings is provided to the public 15 calendar days in advance, and the estimated annual operating cost is listed as $756,918.
Nominations Are Open, and the Practical Meaning Is Not Settled
HHS is now seeking nominations for membership, according to a Federal Register notice reported by the University of Minnesota's Center for Infectious Disease Research and Policy. Appointees serve terms of up to four years. The charter expires July 7, 2028.
What none of this establishes is how the language will be used. A committee could interpret non-immunization strategies narrowly, as guidance for the small number of people with genuine medical contraindications, such as certain immunocompromising conditions, which is an uncontroversial clinical problem. It could also interpret the language expansively.
The revision arrives amid a broader reshaping of federal vaccine advisory bodies. Trade coverage notes that parallel revisions to the ACIP charter drew criticism from infectious disease physicians over governance and meeting predictability.
For readers, the practical situation remains unchanged. Current immunization recommendations remain as clinicians follow them, and no federal body has advised substituting supplements for a vaccine. Anyone weighing vaccination decisions, particularly for a child or an immunocompromised family member, should work through them with a qualified clinician rather than from a charter document.
Key Questions Answered
What is the National Vaccine Advisory Committee?
NVAC is a federal advisory committee that provides advice and recommendations to the Director of the National Vaccine Program, a role held by the Assistant Secretary for Health, on matters related to the program's responsibilities under Section 2105 of the Public Health Service Act.
What changed in the charter?
The objectives section now directs the program and the committee to consider non-immunization strategies for people who cannot or will not be vaccinated, and names healthy lifestyle initiatives, off-label repurposed use of FDA-approved drugs, and dietary supplements as examples of those strategies.
Does this change any vaccine recommendations?
No. NVAC does not set immunization recommendations, and its output is not binding. Recommendations that affect clinical practice and insurance coverage come from the Advisory Committee on Immunization Practices, a separate body that advises the CDC director.
Does the charter say supplements can replace a vaccine?
It does not. The charter names categories of strategy without defining specific products, identifying particular drugs, or citing evidence that any of them substitutes for immunization against a specific pathogen.
How is the committee's membership structured?
There are 17 voting members: 15 public members, including the chair, and two representatives of the vaccine manufacturing industry. Caps the pharmaceutical industry and industry-funded academic representation, and separately academic representation, at no more than one-third each, while public members should be no less than one-third.
How long does the charter last?
It expires on July 7, 2028. NVAC charters are renewed on a two-year cycle in accordance with federal advisory committee rules.
What should patients do with this information?
Nothing about current clinical guidance has changed. People with questions about vaccination, especially for children or immunocompromised family members, should discuss them with a qualified clinician rather than drawing conclusions from an advisory committee charter.
